Table of contents

  • Contents
  • Acknowledgments
  • Abbreviations
  • Symbols
  • Summary
  • Key findings
  • 1 Introduction
    • 1.1 Purpose
    • 1.2 About chronic respiratory conditions
    • 1.3 Structure of the report
  • 2 Key questions for monitoring
  • 3 Data sources
    • 3.1 Pharmaceutical Benefits Scheme (PBS) claims data
    • 3.2 Medicare Benefits Schedule (MBS) claims data
  • 4 PBS and MBS data for reporting on the treatment and management of chronic respiratory conditions
    • 4.1 Questions that can be answered
    • 4.2 Questions that cannot be answered
    • 4.3 Questions that could be answered in the foreseeable future
  • 5 Dispensing of medications for chronic respiratory conditions
    • 5.1 Overall medications dispensed
    • 5.2 Medications dispensed, by class of medication
  • Combination medications (ICS-LABA and LABA-LAMA)
  • Short-acting bronchodilators (includes SABA and SAMA)
  • Long-acting bronchodilators (includes LABA and LAMA)
  • Corticosteroids
  • Leukotriene receptor antagonists (LTRA)
  • Anti-immunoglobulin E therapy (IgE)
  • Other medications
  • 6 Discussion
    • 6.1 Data linkage
    • 6.2 Potential alternative data sources
  • 7 Conclusion
  • Appendix A: PBS and MBS data elements
  • Appendix B: Detailed statistical tables
  • Appendix C: Chronic respiratory conditions PBS medications
  • References